Contact

All Stories

  1. Vascular Endothelial Growth Factor and Soluble Forms of Its Receptors 1 and 2 in Gastric Cancer

    Article • Bulletin of Experimental Biology and Medicine, April 2021, Springer Science + Business Media

    Professor Elena S. Gershtein

  2. Immunosuppression Factors PD-1, PD-L1, and IDO1 and Colorectal Cancer

    Article • Doklady Biochemistry and Biophysics, March 2021, Pleiades Publishing Ltd

    Professor Elena S. Gershtein

  3. Clinical implication of kidney injury molecule (KIM-1) in blood plasma of renal-cell cancer patients

    Article • Cancer Urology, February 2021, Publishing House ABV Press

    Professor Elena S. Gershtein

  4. Comparative Analysis of MMP-8 and MMP-9 Concentrations in Crevicular and Peri-Implants Sulcular Fluids

    Article • Bulletin of Experimental Biology and Medicine, November 2020, Springer Science + Business Media

    Professor Elena S. Gershtein

  5. Key Immune Checkpoint PD-1/PD-L1 Signaling Pathway Components in the Blood Serum from Patients with Bone Tumors

    Article • Bulletin of Experimental Biology and Medicine, November 2020, Springer Science + Business Media

    Professor Elena S. Gershtein

  6. Novel miRNAs as Potential Regulators of PD-1/PD-L1 Immune Checkpoint, and Prognostic Value of MIR9-1 and MIR124-2 Methylation in Ovarian Cancer

    Article • Molecular Biology, November 2020, Pleiades Publishing Ltd

    Professor Elena S. Gershtein

  7. Signaling pathway components of immune checkpoint PD-1/PD-L1 in blood plasma of patients with ovarian cancer and benign ovarian tumors: clinical and morphological correlations

    Article • Akusherstvo i ginekologiia, June 2020, Bionika Media

    Professor Elena S. Gershtein

  8. Prognostic Role of Matrix Metalloproteinases 2, 7, 8, 9 and Their Type 1 Tissue Inhibitor in Blood Serum of Patients with Kidney Cancer

    Article • Bulletin of Experimental Biology and Medicine, March 2020, Springer Science + Business Media

    Professor Elena S. Gershtein

  9. Новые микроРНК как потенциальные регуляторы контрольной точки иммунитета PD-1/PD-L1, и прогностический потенциал метилирования MIR9-1 и MIR124-2 ...

    Article • Молекулярная биология, January 2020, The Russian Academy of Sciences

    Professor Elena S. Gershtein

  10. Kidney Injury Molecule-1 (KIM-1) in Blood Plasma of Patients with Clear-Cell Carcinoma

    Article • Bulletin of Experimental Biology and Medicine, July 2019, Springer Science + Business Media

    Professor Elena S. Gershtein

  11. Comparative Analysis of Blood Plasma Proteome in Patients with Renal Cell Carcinoma

    Article • Bulletin of Experimental Biology and Medicine, May 2019, Springer Science + Business Media

    Professor Elena S. Gershtein

  12. Soluble forms of the immune check-point receptor PD-1 and its ligand PD-L1 in blood serum of patients with renal cell carcinoma: clinical and pathologic correlations

    Article • Cancer Urology, April 2019, Publishing House ABV Press

    Professor Elena S. Gershtein

  13. Clinical Significance of Matrix Metalloproteinases in Blood Plasma of Patients with Gastric Cancer

    Article • Bulletin of Experimental Biology and Medicine, January 2019, Springer Science + Business Media

    Professor Elena S. Gershtein

  14. Soluble Ligand of the Immune Checkpoint Receptor (sPD-L1) in Blood Serum of Patients with Renal Cell Carcinoma

    Article • Bulletin of Experimental Biology and Medicine, January 2019, Springer Science + Business Media

    Professor Elena S. Gershtein

  15. Modern approaches to kidney cancer immunotherapy

    Article • Cancer Urology, July 2018, Publishing House ABV Press

    Professor Elena S. Gershtein

  16. Matrix Metalloproteinases and Their Tissue Inhibitors in Blood Serum of Patients with Endometrial Cancer: Clinical and Morphological Correlations

    Article • Bulletin of Experimental Biology and Medicine, May 2018, Springer Science + Business Media

    Professor Elena S. Gershtein

  17. Receptor Activator of Nuclear Transcription Factor NF-κB (RANK), Its Ligand RANKL, and Natural Inhibitor of RANKL Osteoprotegerin (OPG) in the Blood Serum of Patients with Primary Bone Tumors

    Article • Bulletin of Experimental Biology and Medicine, August 2017, Springer Science + Business Media

    Professor Elena S. Gershtein

  18. Association between the Prevalence of Somatic Mutations in PIK3CA Gene in Tumors and Clinical and Morphological Characteristics of Breast Cancer Patients

    Article • Bulletin of Experimental Biology and Medicine, June 2017, Springer Science + Business Media

    Professor Elena S. Gershtein

  19. RECEPTOR ACTIVATOR OF NUCLEAR TRANSCRIPTION FACTOR NF-B (RANK), ITS LIGAND (RANKL) AND NATURAL INHIBITOR OSTEOPROTEGERIN (OPG) IN BLOOD SERUM OF PRIMARY BONE TUMOR PATIENTS: ASSOCIATION WITH CLINICOPATHOLOGICAL FEATURES AND INFLAMMATORY CYTOKINES LEVELS

    Article • January 2017, RAD Association

    Professor Elena S. Gershtein

  20. Insulin-Like Growth Factors (IGF) and IGF-Binding Proteins (IGFBP) in the Serum of Patients with Ovarian Tumors

    Article • Bulletin of Experimental Biology and Medicine, April 2016, Springer Science + Business Media

    Professor Elena S. Gershtein

  21. Regulatory Proteins of Epithelial-Mesenchymal Transition and Some Components of VEGF Signaling Pathway in Breast Cancer

    Article • Bulletin of Experimental Biology and Medicine, April 2016, Springer Science + Business Media

    Professor Elena S. Gershtein

  22. Clinical prospects of IGF-signaling system components study in ovarian cancer patients

    Article • Drug Metabolism and Personalized Therapy, January 2015, De Gruyter

    Professor Elena S. Gershtein

  23. Insulin-Like Growth Factors (IGF), IGF-Binding Proteins (IGFBP), and Vascular Endothelial Growth Factor (VEGF) in Blood Serum of Patients with Colorectal Cancer

    Article • Bulletin of Experimental Biology and Medicine, March 2014, Springer Science + Business Media

    Professor Elena S. Gershtein

  24. Prognostic Role of Tumor-Associated Proteases in Colorectal Cancer

    Article • Bulletin of Experimental Biology and Medicine, January 2013, Springer Science + Business Media

    Professor Elena S. Gershtein

  25. Matrix Metalloproteinases and Inflammatory Cytokines in Oral Fluid of Patients with Chronic Generalized Periodontitis and Various Construction Materials

    Article • Bulletin of Experimental Biology and Medicine, May 2012, Springer Science + Business Media

    Professor Elena S. Gershtein

  26. Content of Matrix Metalloproteinase-8 and Matrix Metalloproteinase-9 in Oral Fluid of Patients with Chronic Generalized Periodontitis

    Article • Bulletin of Experimental Biology and Medicine, December 2011, Springer Science + Business Media

    Professor Elena S. Gershtein

  27. Relationship between the Expression of VEGF Signal Components and Matrix Metalloproteinases in Ovarian Tumors

    Article • Bulletin of Experimental Biology and Medicine, August 2011, Springer Science + Business Media

    Professor Elena S. Gershtein

  28. Matrix Metalloproteinases 2, 7, and 9 in Tumors and Sera of Patients with Breast Cancer

    Article • Bulletin of Experimental Biology and Medicine, July 2011, Springer Science + Business Media

    Professor Elena S. Gershtein

  29. Vascular Endothelial Growth Factor and Type 2 Receptor for This Factor in Vascular Malformations

    Article • Bulletin of Experimental Biology and Medicine, February 2011, Springer Science + Business Media

    Professor Elena S. Gershtein

  30. The Expression and DNA-Binding Activity of NF-κB Nuclear Transcription Factor in the Tumors of Patients with Breast Cancer

    Article • Bulletin of Experimental Biology and Medicine, November 2010, Springer Science + Business Media

    Professor Elena S. Gershtein

  31. Vascular Endothelial Growth Factor and Its Type 2 Receptor in Hepatocellular Carcinoma

    Article • Bulletin of Experimental Biology and Medicine, October 2010, Springer Science + Business Media

    Professor Elena S. Gershtein

  32. Matrix Metalloproteinases 2, 7, and 9 and Tissue Inhibitor of Metalloproteinases-1 in Tumors and Serum of Patients with Ovarian Neoplasms

    Article • Bulletin of Experimental Biology and Medicine, September 2010, Springer Science + Business Media

    Professor Elena S. Gershtein

  33. Urokinase and Tissue Plasminogen Activators and Their PAI-1 Inhibitor in Tumors of Patients with Oral Mucosal Cancer: Relationship with the Main Clinical Morphological Factors

    Article • Bulletin of Experimental Biology and Medicine, August 2010, Springer Science + Business Media

    Professor Elena S. Gershtein

  34. Matrix Metalloproteinases 2, 7, 9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in the Sera of Patients with Bone Tumors

    Article • Bulletin of Experimental Biology and Medicine, July 2010, Springer Science + Business Media

    Professor Elena S. Gershtein

  35. Molecular Markers of Tumors

    Article • Bulletin of Experimental Biology and Medicine, August 2009, Springer Science + Business Media

    Professor Elena S. Gershtein

  36. Vascular endothelial growth factor and its type 2 receptor in tumors and serum of patients with renal cancer

    Article • Bulletin of Experimental Biology and Medicine, June 2008, Springer Science + Business Media

    Professor Elena S. Gershtein

  37. Matrix metalloproteinases 2, 3, 13 and their type 2 tissue inhibitor in tumors and plasma of patients with colorectal cancer

    Article • Bulletin of Experimental Biology and Medicine, March 2008, Springer Science + Business Media

    Professor Elena S. Gershtein

  38. Expression of VEGF and VEGFR2 in tumors during neoadjuvant therapy of patients with breast cancer

    Article • Bulletin of Experimental Biology and Medicine, February 2008, Springer Science + Business Media

    Professor Elena S. Gershtein

  39. Matrix metalloproteinases 7 and 9 and their types 1 and 4 tissue inhibitors in tumors and plasma of patients with colorectal cancer

    Article • Bulletin of Experimental Biology and Medicine, April 2007, Springer Science + Business Media

    Professor Elena S. Gershtein

  40. Soluble fragment of Her2/neu receptor in the serum of patients with breast cancer with different levels of this protein expression in the tumor

    Article • Bulletin of Experimental Biology and Medicine, April 2007, Springer Science + Business Media

    Professor Elena S. Gershtein

  41. Activation of mitogenic pathways and sensitization to estrogen-induced apoptosis: two independent characteristics of tamoxifen-resistant breast cancer cells?

    Article • Breast Cancer Research and Treatment, September 2006, Springer Science + Business Media

    Professor Elena S. Gershtein

  42. Sensitization of MCF-7 breast cancer cells to the apoptotic effect of estradiol

    Article • Bulletin of Experimental Biology and Medicine, March 2006, Springer Science + Business Media

    Professor Elena S. Gershtein

  43. Activated Proteinkinase B in Breast Cancer

    Article • Bulletin of Experimental Biology and Medicine, May 2005, Springer Science + Business Media

    Professor Elena S. Gershtein

  44. Role of Phosphatidylinositol-3 Kinase in Regulation of Differential Sensitivity of Melanoma Cells to Antitumor Agents. A Model for Hormone Resistance Development in Tumor Cells

    Article • Biochemistry (Moscow), March 2004, Springer Science + Business Media

    Professor Elena S. Gershtein

  45. Article • Molecular Biology, January 2003, Springer Science + Business Media

    Professor Elena S. Gershtein

  46. Article • Bulletin of Experimental Biology and Medicine, January 2003, Springer Science + Business Media

    Professor Elena S. Gershtein

  47. Article • Bulletin of Experimental Biology and Medicine, January 2002, Springer Science + Business Media

    Professor Elena S. Gershtein

  48. Article • Bulletin of Experimental Biology and Medicine, January 2001, Springer Science + Business Media

    Professor Elena S. Gershtein

  49. Article • Bulletin of Experimental Biology and Medicine, January 2001, Springer Science + Business Media

    Professor Elena S. Gershtein

  50. Article • Bulletin of Experimental Biology and Medicine, January 2001, Springer Science + Business Media

    Professor Elena S. Gershtein

  51. Phospatidylinositol 3-kinase expression in human breast cancer

    Article • Clinica Chimica Acta, September 1999, Elsevier

    Professor Elena S. Gershtein

  52. The role of phosphatidylinositol 3-kinase in the regulation of cell response to steroid hormones

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, July 1999, Elsevier

    Professor Elena S. Gershtein

  53. Receptors for the epidermal growth factor and estrogens in primary bone tumors

    Article • Bulletin of Experimental Biology and Medicine, July 1996, Springer Science + Business Media

    Professor Elena S. Gershtein

  54. Comparative analysis of the sensitivity of endometrial cancer cells to epidermal growth factor and steroid hormones

    Article • Cancer, December 1995, Wiley

    Professor Elena S. Gershtein

  55. Action of tamoxifen on the reproductive organs of guinea pigs

    Article • Bulletin of Experimental Biology and Medicine, December 1982, Springer Science + Business Media

    Professor Elena S. Gershtein

  56. Changes in relations between two pathways of synthesis of RNA precursors in the tissues of animals with fast growing hepatomas

    Article • Bulletin of Experimental Biology and Medicine, March 1979, Springer Science + Business Media

    Professor Elena S. Gershtein

  57. The structure of the diamino dicarboxylic amino acids from the glycopeptide antibiotic ristomycin A

    Article • Chemistry of Natural Compounds, January 1978, Springer Science + Business Media

    Professor Elena S. Gershtein